Nolsterby Invest AB

Overview

Nolsterby Invest AB is a family office based in the Stockholm-Uppsala region, focusing on investments in the healthcare sector. The firm categorizes healthcare into subsectors such as Medtech, Diagnostics, Biotech, Life Science Tools & Supplies, and Healthtech. Their primary expertise lies in Medtech companies at the growth stage with clear clinical applications. While they have invested in other subsectors, these typically involve smaller ticket sizes compared to Medtech investments. The firm's deal flow originates from both unlisted and listed environments. In their investment approach, Nolsterby Invest emphasizes understanding market uptake by evaluating clinical evidence, regulatory landscapes, payer dynamics, user adoption, and business models. They prioritize investing in skilled entrepreneurs and managers, often co-investing with trusted partners. Their long-term perspective is evident in their evergreen investment strategy, without an explicit exit plan, and they actively engage in their holdings through board representation and other means. The firm's portfolio includes companies like Integrum, Occlutech, Perpetua Medical, Stille, Acousort, Capitainer, Devyser, Oncodia, Akiram Therapeutics, TIRmed Pharma, Peptisystems, Collective Minds Radiology, Encare, and Younium. These investments reflect Nolsterby Invest's commitment to advancing healthcare through strategic partnerships and active ownership. Nolsterby Invest AB is majority-owned by Erik Hedlund, a serial entrepreneur in medical technology, and has been fully operational since 2021 when Anders Hedlund joined as CEO. The firm operates with a long-term investment horizon, focusing on creating value through active ownership and strategic guidance in the healthcare sector.

Investment Focus

• Strong clinical evidence
• Clear market adoption potential
• Experienced management teams
• Alignment with value-based care models
• Co-investment with trusted partners

Portfolio Companies